Literature DB >> 20926879

Timing and indications for colectomy in chronic ulcerative colitis: Surgical consideration.

Robert R Cima1.   

Abstract

Total proctocolectomy (TPC) cures a patient of the intestinal manifestation of chronic ulcerative colitis. The timing of surgery during the illness will influence the choice of operation, the frequency of post-operative complications, and the long-term functional outcomes. Surgery is divided into emergency, urgent, and elective procedures. Emergency cases are performed for complications of fulminant colitis: hemorrhage, perforation, toxic megacolon or sepsis. A subtotal colectomy (STC) with a Brooke ileostomy (BI) is the procedure of choice. STC removes the bulk of the disease, allows the patient's health to be restored, medication to be withdrawn, and permits a future restorative operation. Urgent operations occur in hospitalized patients with continued symptoms after seven days of maximal medical therapy. Once again the preferred operation is a STC-BI. Indications for elective colectomy include: persistent symptoms despite maximal medical therapy, medication side-effects, persistent chronic disease state, dysplasia/malignancy. Elective surgical options include TPC-BI, TPC with ileal-pouch anal anastomosis (IPAA), or STC-BI. The choice of operation is based upon patient preference and preoperative physiologic and functional status. Factors associated with increased post-operative complications are weight loss >10%, multiple preoperative blood transfusions, albumin <3.0 gm/dl, and degree of immuno-suppression. In high-risk patients, STC-BI should be performed. IPAA can be performed later after the patient's health is restored. In conclusion, numerous factors affect the timing and choice of operation in patients with CUC. Avoiding complications in IPAA patients is essential as they negatively impact the long-term function and durability of the IPAA.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20926879     DOI: 10.1159/000320409

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  16 in total

Review 1.  Surgical treatment of ulcerative colitis in the biologic therapy era.

Authors:  Alberto Biondi; Marco Zoccali; Stefano Costa; Albert Troci; Ettore Contessini-Avesani; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

2.  Free peritoneal perforation in a patient with Crohn's disease - Report of a case.

Authors:  Raquel Franco Leal; Marc Ward; Maria de Lourdes Setsuko Ayrizono; Nielce Maria de Paiva; Emanuelle Bellaguarda; Débora Helena Gonçalves Rossi; Natália Pranzetti Vieira; João José Fagundes; Cláudio Saddy Rodrigues Coy
Journal:  Int J Surg Case Rep       Date:  2013-01-23

3.  [Proctocolectomy in ulcerative colitis : is a multistep procedure in cases of immunosuppression advisable?].

Authors:  C Seifarth; J Gröne; N Slavova; B Siegmund; H J Buhr; J-P Ritz
Journal:  Chirurg       Date:  2013-09       Impact factor: 0.955

4.  Identification of pathologic features associated with "ulcerative colitis-like" Crohn's disease.

Authors:  Samuel D James; Paul E Wise; Tania Zuluaga-Toro; David A Schwartz; M Kay Washington; Chanjuan Shi
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 5.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

6.  High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival.

Authors:  Che-Yung Chao; Alex Al Khoury; Achuthan Aruljothy; Sophie Restellini; Jonathan Wyse; Waqqas Afif; Alain Bitton; Peter L Lakatos; Talat Bessissow
Journal:  Dig Dis Sci       Date:  2018-11-16       Impact factor: 3.199

7.  Impact of staged surgery on quality of life in refractory ulcerative colitis.

Authors:  Claudia Seifarth; Lara Börner; Britta Siegmund; Heinz Johannes Buhr; Jörg-Peter Ritz; Jörn Gröne
Journal:  Surg Endosc       Date:  2016-06-17       Impact factor: 4.584

8.  A comprehensive review of inflammatory bowel disease focusing on surgical management.

Authors:  Seung Hyuk Baik; Won Ho Kim
Journal:  J Korean Soc Coloproctol       Date:  2012-06-30

9.  Indian Society of Gastroenterology consensus on ulcerative colitis.

Authors:  Balakrishnan S Ramakrishna; Govind K Makharia; Philip Abraham; Uday C Ghoshal; Venkataraman Jayanthi; Brij Kishore Agarwal; Vineet Ahuja; Deepak K Bhasin; Shobna J Bhatia; Gourdas Choudhuri; Sunil Dadhich; Devendra C Desai; Gopal Krishna Dhali; Bhaba Dev Goswami; Sanjeev K Issar; Ajay K Jain; Rakesh Kochhar; Ajay Kumar; Goundappa Loganathan; Sri Prakash Misra; C Ganesh Pai; Sujoy Pal; Anna Pulimood; Amarender S Puri; Ganesh N Ramesh; Gautam Ray; Shivaram P Singh; Ajit Sood; Manu Tandan
Journal:  Indian J Gastroenterol       Date:  2012-10-25

10.  Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis.

Authors:  Christopher J Damman; Mitchell J Brittnacher; Maria Westerhoff; Hillary S Hayden; Matthew Radey; Kyle R Hager; Sara R Marquis; Samuel I Miller; Timothy L Zisman
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.